Cell & Gene Therapies The logistics of providing life saving, industry changing treatments

Similar documents
Cold-Chain & Logistical Challenges of Cell Therapeutics in Clinical Trials

First Quarter Trusted by the Life Sciences Industry

Corporate Presentation NASDAQ: CYRX

Cold Chain Custody Quality Aspects. Nigel Bleakley Associate Director Validation 16 Feb, 2015

THE HEARTBEAT OF THE LIFE SCIENCES INDUSTRY: DHL MEDICAL EXPRESS

TIME SAVER LIFE SAVER

CHINA. Australia - China Life Science Summit. . Bio & Pharma Logistics

Ensuring Near-Perfect On-Time Performance

TIME SAVER LIFE SAVER

AVINEX MEDICAL LOGISTICS IN RUSSIA AND UKRAINE

Whitepaper. Small Molecule Vs Cell Therapy Clinical Trial Supply Chain. Martin Lamb, Executive Vice President for Sales and Marketing

Go! Express & logistics

Cold Chain Planning for Clinical Studies of Regenerative Medicines

Trusted by the Life Sciences Industry

Temperature Controlled Distribution of Biologics. September 11 th 2018 The Alexandria at Torrey Pines, San Diego.

Healthcare Supply Chain Solutions

SUPPLY CHAIN AND LOGISTICS FOR ADVANCED THERAPIES

Cold Chain Committee Guidance for shippers, transport service providers and subcontractors

CRYOPORT, INC. (NASAQ: CYRX) (NASDAQ: CYRXW) FISCAL YEAR 2018 IN REVIEW MARCH 7, 2019

Top 10 Questions to Ask Your Clinical Supply Vendor about Temperature Sensitive Drugs

MOLECULAR DIAGNOSTICS TESTING: Industry Overview and SCM Challenges

Freight Forward & Logistics in Miami Florida

YOUR COLDCHAIN PARTNER

Life Sciences & Pharmaceuticals Conference - LHR November Bourji Mourad Global Head Partner Management

Companies use DHL because we make their lives easier through

Corso di Laurea Magistrale in Chimica e Tecnologia Farmaceutiche E25

LifeScience Logistics Achieves 99.97% Inventory Accuracy with TECSYS WMS for Healthcare

Logistic Provider Qualification: prerequisites and SLA

Cryoport, Inc. Calendar Year 2017 Third Quarter Earnings Call NASDAQ: CYRX

This video gives an overview of the centralised procedure at the European Medicines Agency

C3M Continuous Cold Chain Management. Active Monitoring Solutions for the Pharmaceutical Industry. Validating Asset Integrity

CASE STUDY: PACKAGING QUALIFICATION WITH INTEGRATED COLD CHAIN LOGISTICS DESIGN

Global Integrated Solutions. Advanced Therapy Clinical Development and Commercialization

Traceability of Autologous Drug Product from Cell Procurement through Infusion

Transporting Biological Materials Training UCCBB

Designing a Disruptive Life Sciences Cold Chain Logistics Platform

Precision Biospecimen Solutions: Paving the Way to Personalized Medicine

Cell Therapy Logistics

Sharon Tindle, MS, CQA (ASQ) QA Manager, BMT Tissue Services Mount Sinai Hospital, New York, NY. June 7, 2016

Global Contract Research Organization (CRO) Market: Size, Trends & Forecasts ( ) November 2017

H O W T O C O M P L Y W I T H T H E C O N F O R M I T Y A S S E S S M E N T P R O G R A M M E I N N I G E R I A

The critical role of shipping & logistics in the commercialization of cord blood therapies

How are forwarders addressing the demands of shippers for cost effective air distribution of pharmaceuticals?

ZETA. the Perfect Service. demand driven world demand driven logistics

Regulatory Support to EU Research

Brussels Airport Gateway for the time and temperature controlled supply chain

ABF Pharmaceutical Services GmbH

Considerations When Using Advanced Packaging Materials Richard Wood Design Manager, Peli BioThermal

A PROCESS VALIDATION GUIDE FOR COLD CHAIN LOGISTICS: ENSURING COMPLIANCE GLOBALLY

Pharma Market Growth and The Cost of Doing Business

Clinical Trials: Facts and Trends. Dr Nik Nikitin. Founder/Director, Russlan Clinical. ManxBioMed Annual Bio Business Conference 10 th December 2013

Dr. Abdulrahman Mohammad Al Jassmi Chief Executive Officer Dubai Hospital Dubai Health Authority

CMC Strategy Forum Prague Enda Moran EBE Satellite Session, 06 May 2013

CCA AGM 2013 Brussels, May In Health Science Logistics, is the Airport the Weakest Link?

Challenges in Commercialization of Autologous Cell Therapy Products. Bryan Silvey & Kanti Thirumoorthy Kite Quality

Reducing Risk and Costs in the Global Supply Chain

Review and highlight existing guidance documents that address pharmaceutical stability and supply chain issues. 3.) Solution

The European Medicines Agency: A well-established Agency of the EU protecting human and animal health for all EU citizens

WHAT S NEXT FOR STERILE CONTRACT MANUFACTURING IN EMERGING MARKETS?

Oursourcing and Supplier Qualification from the perspective of the pharmaceutical Industry

Quality development considerations - Regulatory perspective

Int. J. Pharm. Sci. Rev. Res., 31(2), March April 2015; Article No. 04, Pages: A Review on Drug Approval in Regulated and Non-Regulated Markets

Francisco Rizzuto IATA Cargo Manager for Western Europe Specialized in Temperature Controlled Shipments for Pharmaceuticals

Overview Rentschler Biotechnologie

Hospital Express. Reliable, cost-effective delivery to and from every hospital in Europe

INTERNATIONAL SHIPPING GUIDE. Send testing to Mayo Clinic from around the world

Health Care Logistics: an Enabler of Change BioLogistics in a Changing Healthcare World Northwestern University Transportation Center

Recent Opportunities & Challenges in microbial manufacturing

Temperature-Controlled Products. Logistics Solutions for Cold Chain Distribution

Among the basics of building a

Real solutions for real-world problems.

Copyright 2009, International Society for Biological and Environmental Repositories (ISBER)

Supplier Qualification and Regulatory Compliance in International Biopharm Logistics. November 19 th, Copenhagen, 2015

Practical and Value Generating Approach to IATA Chapter 17 7 th Edition of the Perishable Cargo Regulations -- David Y. Bang

BEST-IN-CLASS FORMULATIONS PROVIDE SIGNIFICANT COMPETITIVE ADVANTAGES

QS, GDP (+GMP?) Maintaining the Integrity of The Supply Chain

AllCargo Company Presentation 11/2017. Menu. Introduction

BioProcess Technology Consultants, Inc. Helping Clients De-Risk Biopharmaceutical Development Since 1994

Technology of cell therapies

Healthy solutions for the healthcare industry.

FACT Common Standards for Cellular Therapies, Second Edition. Summary of Changes

HEALTHCARE PEOPLE: TEST MEDICATION

BIOSCIENTIA. Good outcomes are based on good values. Central lab services and biomarker analytics for clinical trials

Investor Presentation

GDP for APIs New Regulations. we prove it. The Shift to Monitoring BioPharma Product Quality Throughout Their Lifecycle

We are a supply chain management company providing complete solutions for critical logistics, globally.

THERAPEUTIC AREAS CARDIOVASCULAR RESEARCH

Challenges during the development of ATMPs

FDA Perspectives On Viral & Vector Shedding Studies. Daniel Takefman, Ph.D. Chief, Gene Therapy Branch FDA/CBER ICH Workshop: October 31, 2007

"From Bedside to Bench and Back: regulatory requirements for collaborations between pharma industry and academia

Precision Medicine. Presented by:

Process Transfer Excellence Basis for a fast and successful project

Advanced Phase Change Materials (PCMs):

Type of Activity. Universal Activity Number L04-P

Calendar. The Clear Solution to Reach the Global Biopharma Audience. INTERNATIONAL

The era of biological medicines

Practical Approaches to Temperature Controlled Pharmaceutical Logistics and Storage. April 12 th & 13 th 2016 Hotel BLOOM!

Andrew Finnerty General Manager - CCMI

Details: Approval: Distribution & Storage:

The largest network of harmonized bio/ pharmaceutical GMP product testing labs worldwide, Eurofins BioPharma Product Testing enables companies to

Transcription:

Cell & Gene Therapies The logistics of providing life saving, industry changing treatments PharmaInsight Briefings CPhI Europe Frankfurt, 25 th September 20187

Cell and Gene Therapy History Cell Therapy: originated in the 1950s (blood transfusions) Gene Therapy: conceptualized in the 1970s. Patient research began in the 1990s 16/11/2016 CONFIDENTIAL

Cell and gene therapies are biopharma products that utilize living cells and/ or genetic material to fight diseases 16/11/2016 CONFIDENTIAL

Current Cell & Gene Therapy Activity Sample of Current Cell & Gene Therapy Customer Locations +55% +55% Active Gene Therapy +45% +45% Active Cell Therapy 16/11/2016 CONFIDENTIAL

So, What s the big deal? 1 in 3 people will develop some form of cancer during their lifetime 1,500+ diseases are caused by a single defective gene EU approved first gene therapy treatment 90% Gene-based clinical trials have increased by almost 90% since 2009 By 2020, the global regenerative market is expected to reach over $67 billion 1. "Lifetime Risk of Developing or Dying From Cancer." Lifetime Risk of Developing or Dying From Cancer. American Cancer Society, 23 Mar. 2016. Web. 04 May 2016. <http://www.cancer.org/cancer/cancerbasics/lifetime-probability-of-developing-or-dying-from-cancer>. 2. McCain, Jack. "The Future of Gene Therapy." Biotechnology Healthcare. BioCommunications LLC, n.d. Web. 04 May 2016. <http://www.ncbi.nlm.nih.gov/pmc/articles/pmc3564347/>. 3. Moran, Nuala. "Glybera Gains Official EMA Nod as First Gene Therapy."BioWorld. N.p., 2012. Web. 04 May 2016. <http://www.bioworld.com/content/glyberagains-official-ema-nod-first-gene-therapy-0>. 4. "Gene Therapy Clinical Trials Worldwide." Gene Therapy Clinical Trials Worldwide. John Wiley and Sons Ltd, 2015. Web. 04 May 2016. <http://www.wiley.com//legacy/wileychi/genmed/clinical/>. 5. "MarketResearchReports.Com: Global Regenerative Medicine Market Is Expected to Reach $67.6 Billion by 2020, Reveals New Report." - Press Release. N.p., 2014. Web. 05 May 2016. <http://www.digitaljournal.com/pr/2120366>. 5

Why this business is important to World Courier Clinical supply chain virtually same as commercial supply chain Unique requirements suited for specialty courier service Competitive landscape 16/11/2016 CONFIDENTIAL

How hard can it be? Complex criteria requirements include: Strict temperature ranges and qualification of transportation systems Extremely tight turnaround timelines typically 18 to 36 hours Short Lead Times, Collections and deliveries 24/7, weekends and holidays Unique logistics limitations such as inability to x-ray Cross border shipment challenges and regulations 7

Cell Therapy and the Circular Supply Chain 16/11/2016 CONFIDENTIAL

Types of shipment in the circular supply chain Apheresis samples: High importance, lifespan, temp control Finished product: Frozen (LN2 or dry ice) Tumor samples: Sent to a lab for storage, analysis QC samples: Sent to a lab for analysis 16/11/2016 CONFIDENTIAL

Important Service Factors Tight transit time requirements Chain of Custody Communication / Visibility Packaging 16/11/2016 CONFIDENTIAL

What could possibly go wrong? 11

How important is your shipment? 12

The World Courier Way Study Specific SOPs Training AT All Levels Technical & Quality SLAs Airline Buy In and Understanding Certificated Airports, Hand Searches Transport Plan Recommended airports and airlines use data including hours of operation, lockout and recovery and performance for analysis Latest pick up times Best transport mode

Cell Therapy Clinical Trial: Phase II months 245 shipments 63 patients 39 destination sites 2,066.4 KGs of materials transported 1 FDA fast track designation 14

39 Destinations. 24 Hours. 15

Packaging Preparation Transport System Shipping at 2 to 8 degrees Celsius (GTC size 4) Liquid nitrogen dry vapor shipper Vacuum insulated panel boxes with PCM Qualification Months of challenging packaging TiltWatch monitor stickers 80 percent of shippers pre-charged with liquid nitrogen by client 16

Plan, Anticipate, Manage, Repeat Study-specific SOPs Customer SOPs Quality Agreement Technical Agreement/Annex to Quality Agreement Training at 16 investigational sites Shipping manuals Weekly client teleconference calls, 5 minutes to 1 hour I am convinced World Courier is the best option in terms of temperature controlled transports over different borders. 17

Air Time, In Time Transport challenges and solutions: Non X-ray/Customs - Hand carry authorizations Short close out times - small/responsive regional airports vs. global hubs Import Regulations for Thermo Boxes. Russia and Ukraine -.e.g ensuring temporary imports to Russia and Ukraine World Courier did a great job reviewing all the airports that we needed for trial, checking the routing and X-ray exemption status. 18

Making a World of Difference Consultation Training Knowledge sharing Status communication Practical problem solving 19

World Courier = Peace of Mind

Contact me: Martin Pohle Branch Manager World Courier (Deutschland) GmbH An AmerisourceBergen Company Email: mpohle@worldcourier.de http://www.worldcourier.com https://de.linkedin.com/in/martinpohle 21